|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | |
| G01N 33/15 | |||
| C12Q 1/68 | |||
| G06F 19/18 |
| (11) | Number of the document | 2630489 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11835118.8 |
| Date of filing the European patent application | 2011-10-20 | |
| (97) | Date of publication of the European application | 2013-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/057007 |
| Date | 2011-10-20 |
| (87) | Number | WO 2012/054681 |
| Date | 2012-04-26 |
| (30) | Number | Date | Country code |
| 405272 P | 2010-10-21 | US |
| (72) |
MRAZEK, David A., US
|
| (73) |
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH,
200 First Street S.W., Rochester, MN 55905,
US
|
| (54) | METHODS FOR SELECTING MEDICATIONS FOR TREATING PATIENTS HAVING ATTENTION-DEFICIT HYPERACTIVITY DISORDER |
| METHODS FOR SELECTING MEDICATIONS FOR TREATING PATIENTS HAVING ATTENTION-DEFICIT HYPERACTIVITY DISORDER |